- Home
- PSMT vs KYMR Comparison
PSMT vs KYMR Comparison
Compare PSMT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSMT
- KYMR
- Stock Information
- Founded
- PSMT 1994
- KYMR 2015
- Country
- PSMT United States
- KYMR United States
- Employees
- PSMT N/A
- KYMR N/A
- Industry
- PSMT Department/Specialty Retail Stores
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- PSMT Consumer Discretionary
- KYMR Health Care
- Exchange
- PSMT Nasdaq
- KYMR Nasdaq
- Market Cap
- PSMT 2.7B
- KYMR 2.2B
- IPO Year
- PSMT 1997
- KYMR 2020
- Fundamental
- Price
- PSMT $86.05
- KYMR $29.62
- Analyst Decision
- PSMT Strong Buy
- KYMR Buy
- Analyst Count
- PSMT 1
- KYMR 13
- Target Price
- PSMT $90.00
- KYMR $56.69
- AVG Volume (30 Days)
- PSMT 292.5K
- KYMR 597.4K
- Earning Date
- PSMT 04-09-2025
- KYMR 05-01-2025
- Dividend Yield
- PSMT 1.46%
- KYMR N/A
- EPS Growth
- PSMT 23.18
- KYMR N/A
- EPS
- PSMT 4.54
- KYMR N/A
- Revenue
- PSMT $5,005,367,000.00
- KYMR $47,072,000.00
- Revenue This Year
- PSMT $8.79
- KYMR $44.93
- Revenue Next Year
- PSMT $9.69
- KYMR N/A
- P/E Ratio
- PSMT $18.96
- KYMR N/A
- Revenue Growth
- PSMT 10.65
- KYMR N/A
- 52 Week Low
- PSMT $77.51
- KYMR $29.07
- 52 Week High
- PSMT $99.23
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- PSMT 47.46
- KYMR 33.94
- Support Level
- PSMT $85.13
- KYMR $29.83
- Resistance Level
- PSMT $87.57
- KYMR $35.28
- Average True Range (ATR)
- PSMT 2.01
- KYMR 1.79
- MACD
- PSMT 0.35
- KYMR -0.20
- Stochastic Oscillator
- PSMT 63.72
- KYMR 4.54
About PSMT PriceSmart Inc.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.